Compare NEO & PWP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEO | PWP |
|---|---|---|
| Founded | 2001 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1999 | N/A |
| Metric | NEO | PWP |
|---|---|---|
| Price | $11.87 | $17.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $12.56 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 1.8M | 707.0K |
| Earning Date | 10-28-2025 | 11-07-2025 |
| Dividend Yield | N/A | ★ 1.57% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.70 |
| Revenue | $709,162,000.00 | ★ $757,415,000.00 |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | $9.88 | $38.06 |
| P/E Ratio | ★ N/A | $25.62 |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $4.72 | $14.12 |
| 52 Week High | $19.12 | $27.03 |
| Indicator | NEO | PWP |
|---|---|---|
| Relative Strength Index (RSI) | 60.77 | 44.18 |
| Support Level | $11.59 | $17.85 |
| Resistance Level | $12.26 | $18.97 |
| Average True Range (ATR) | 0.42 | 0.57 |
| MACD | -0.07 | 0.09 |
| Stochastic Oscillator | 49.80 | 22.76 |
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Perella Weinberg Partners is an independent advisory firm that provides strategic and financial advice to a wide range of clients. The Company's activities as an investment banking advisory firm constitute a single business segment that provides a range of advisory services, including advice related to strategic and financial decisions, mergers and acquisitions execution, shareholder and defense advisory, financing and capital solutions advice with resources focused on restructuring and liability management, capital markets advisory, private capital placement, as well as specialized underwriting and research services for the energy and related industries.